0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Propranolol Compared with Propranolol plus Isosorbide-5-Mononitrate for Portal Hypertension in Cirrhosis: A Randomized Controlled Study

Joan Carles GarcÍa-Pagán, MD; Faust Feu, MD; Jaume Bosch, MD; and Joan Rodés, MD
[+] Article and Author Information

Grant Support: In part by the Fundacio Catalana per a L'Estudi de les Malalties del Fetge and Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS-91/0734). Dr. GarcÍa-Pagán held a research fellowship from the FISS (89/1516).

Requests for Reprints: Jaume Bosch, MD, Hepatic Hemodynamics Laboratory, Liver Unit, Hospital Clinic i Provincial, C/. Villaroel 170, 08036 Barcelona, Spain.

Current Author Addresses: Drs. GarcÍa-Pagán, Feu, Bosch, and Rodés: Hepatic Hemodynamics Laboratory, Liver Unit, Hospital Clinic i Provincial, C/. Villaroel 170, 08036 Barcelona, Spain.


© 1991 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1991;114(10):869-873. doi:10.7326/0003-4819-114-10-869
Text Size: A A A
This excerpt has been provided in the absence of an abstract.

Objective: To investigate whether isosorbide-5-mononitrate (Is5-Mn) given with propranolol reduces hepatic portal pressure more than does propranolol alone in patients with cirrhosis.

Design: A randomized controlled trial.

Patients: Fifty patients with cirrhosis and esophageal varices entered and 42 completed the study.

Intervention: Twenty-one patients received oral propranolol at increasing doses until their resting heart rate was reduced by 25%, and 21 patients received oral propranolol (on the same schedule) plus oral Is-5-Mn, 40 mg twice a day.

Measurements: Hepatic vein pressure gradient, liver function, and splanchnic and systemic hemodynamics before and after 3 months of continuous therapy.

Main Results: At 3 months, the hepatic venous pressure gradient decreased more (P < 0.01) in patients given propranolol plus Is-5-Mn (19%, from 18.4 ± 3.9 to 14.9 ± 3.8 mm Hg; 95% CI, - 2.4 to -4.5 mm Hg) than in those given propranolol alone (10%, from 18.2 ±3.5 to 16.3 ±3.1 mm Hg; CI, - 1.1 to - 2.7 mm Hg). The hepatic venous pressure gradient decreased by more than 20% of the baseline value in 10% of patients receiving propranolol, but in 50% of patients receiving combined therapy (P < 0.02). There were statistically significant decreases in hepatic blood flow and the intrinsic clearance of indocyanine green after propranolol therapy, but not after combined therapy. The treatments caused similar reductions in azygos blood flow and cardiac output.

Conclusions: The long-term combined administration of propranolol plus Is-5-Mn reduces portal pressure more than propranolol alone without adverse effects on hepatic perfusion and liver function. Whether this greater hemodynamic effect translates into better clinical efficacy should be determined in randomized controlled trials.

...

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)